A456070 Share Price Performance
₩17,320.00
-1780.00 (-9.32%)
Price ₩17,320.00
Share Pricen/a
No recently updated narratives available.
ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease. It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea.